Medicalgorithmics SA stock news
Medicalgorithmics SA has entered into an agreement with its major shareholder, Biofund Capital Management LLC, to establish a new loan line of up to $3 million (approximately PLN 12 million). The financing is designated for specific strategic projects, including technology development, research and development, and potential mergers and acquisitions. The loan facility is available for four years and can be drawn in tranches of up to $1 million. This agreement provides the company with significant financial flexibility to fund its expansion and innovation initiatives following the recent restructuring of its balance sheet.